These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
143 related articles for article (PubMed ID: 6216780)
1. Pharmacology and pharmacokinetics of platelet-active drugs under current clinical investigation. FitzGerald GA; Sherry S Adv Prostaglandin Thromboxane Leukot Res; 1982; 10():107-72. PubMed ID: 6216780 [No Abstract] [Full Text] [Related]
2. [Pharmacology of anti-platelet agents]. Lecompte T; Kher A; Gaillard JL; Samama M J Mal Vasc; 1983; 8(1):3-16. PubMed ID: 6302191 [TBL] [Abstract][Full Text] [Related]
3. Aspirin and other platelet-aggregation inhibiting drugs. Gallus AS Med J Aust; 1985 Jan; 142(1):41-7. PubMed ID: 3880861 [TBL] [Abstract][Full Text] [Related]
4. The human pharmacology of platelet inhibition: pharmacokinetics relevant to drug action. Pedersen AK; FitzGerald GA Circulation; 1985 Dec; 72(6):1164-76. PubMed ID: 3905047 [No Abstract] [Full Text] [Related]
5. A perspective on platelet-suppressant drug treatment in coronary artery and cerebrovascular disease. Genton E Circulation; 1980 Dec; 62(6 Pt 2):V111-21. PubMed ID: 6108166 [No Abstract] [Full Text] [Related]
6. Role of platelet-active drugs in coronary artery disease. Sherry S Cardiovasc Clin; 1983; 14(1):173-89. PubMed ID: 6352025 [No Abstract] [Full Text] [Related]
7. Platelet-active drugs in the secondary prevention of cardiovascular events: an overview. Weiss HJ Circulation; 1980 Dec; 62(6 Pt 2):V41-3. PubMed ID: 7002351 [TBL] [Abstract][Full Text] [Related]
8. [Platelets and prostaglandins in ischemic cardiopathy. Theoretical and practical aspects and research prospects]. Verdecchia P Clin Ter; 1982 Apr; 101(2):179-94. PubMed ID: 7047054 [No Abstract] [Full Text] [Related]
9. Effect of prostaglandin-mediated platelet-suppressant drugs on acute cardiovascular catastrophes. Sherry S Adv Prostaglandin Thromboxane Leukot Res; 1982; 10():173-210. PubMed ID: 6216782 [No Abstract] [Full Text] [Related]
10. Platelets. Hirsh J Can Med Assoc J; 1973 Feb; 108(4):416 passim. PubMed ID: 4687370 [No Abstract] [Full Text] [Related]
11. Efficacy of antiplatelet drugs in the maintenance of aortocoronary vein bypass graft patency. Gitler B; Gitler ES Am Heart J; 1983 Sep; 106(3):563-70. PubMed ID: 6410893 [No Abstract] [Full Text] [Related]
13. [Blood platelets and myocardial infarction]. MusiaĆ J; Dworski R; Szczeklik A Pol Tyg Lek; 1984 Dec; 39(50):1665-8. PubMed ID: 6396594 [No Abstract] [Full Text] [Related]
14. A critical appraisal of the clinical efficiency of anti-platelet drugs. Lecompte T; Samama M Agents Actions Suppl; 1986; 20():203-14. PubMed ID: 3544741 [No Abstract] [Full Text] [Related]
15. Mode of action of currently used antiplatelet drugs. de Gaetano G; Bertele' V; Cerletti C Agents Actions Suppl; 1986; 20():191-201. PubMed ID: 3101442 [No Abstract] [Full Text] [Related]
16. Antiplatelet agents: their role in the prevention of sudden death. Hirsh J Ann N Y Acad Sci; 1982; 382():289-304. PubMed ID: 7044244 [No Abstract] [Full Text] [Related]
18. 10. Antithrombotic therapy: role of platelet-inhibitor drugs. II. Pharmacologic effects of platelet-inhibitor drugs (second of three parts). Fuster V; Chesebro JH Mayo Clin Proc; 1981 Mar; 56(3):185-95. PubMed ID: 7010003 [TBL] [Abstract][Full Text] [Related]
19. The current status of platelet suppressive drugs in the treatment of thrombosis. Hirsh J; Gent M; Genton E Thromb Diath Haemorrh; 1975 Jun; 33(3):406-16. PubMed ID: 1098213 [No Abstract] [Full Text] [Related]